Review article: direct‐acting antivirals for the treatment of HCV during pregnancy and lactation ‐ implications for maternal dosing, foetal exposure, and safety for mother and child

BACKGROUND: With the global efforts to eradicate hepatitis C virus (HCV), treatment during pregnancy is becoming a priority for research as this, and maternal cure should reduce vertical transmission. However, as information on the efficacy and safety of direct‐acting antivirals (DAAs) in pregnancy...

Descripción completa

Detalles Bibliográficos
Autores principales: Freriksen, Jolien J. M., van Seyen, Minou, Judd, Ali, Gibb, Diana M., Collins, Intira J., Greupink, Rick, Russel, Frans G. M., Drenth, Joost P. H., Colbers, Angela, Burger, David M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Review Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6773363/
https://www.ncbi.nlm.nih.gov/pubmed/31448450
http://dx.doi.org/10.1111/apt.15476

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6773363/
https://www.ncbi.nlm.nih.gov/pubmed/31448450
http://dx.doi.org/10.1111/apt.15476

Ejemplares similares